T. E. WOODWARD, M.D.; H. E. HALL, M.D.; R. DIAS-RIVERA, M.D.; J. A. HIGHTOWER, M.D.; E. MARTINEZ, M.D.; R. T. PARKER, M.D.
This content is PDF only. Please click on the PDF icon to access.
Despite the obvious benefits of chloramphenicol therapy in typhoid fever,1, 2 there are several problems in this disease which remain to be solved: (1) The present chloramphenicol regimens do not alleviate the toxemia of the disease for at least 36 to 48 hours and fail to eliminate the fever until about the fourth day; (2) relapses of typhoid fever occur in a certain percentage of treated patients3; (3) Salmonella typhosa continues to be shed in the feces for variable periods of time after therapy is begun,2 and (4) the typhoid carrier state when it exists is not permanently benefited by
WOODWARD TE, HALL HE, DIAS-RIVERA R, et al. TREATMENT OF TYPHOID FEVER. II. CONTROL OF CLINICAL MANIFESTATIONS WITH CORTISONE*. Ann Intern Med. 1951;34:10–19. doi: https://doi.org/10.7326/0003-4819-34-1-10
Download citation file:
Published: Ann Intern Med. 1951;34(1):10-19.
Hospital Medicine, Infectious Disease, Prevention/Screening, Vaccines/Immunization.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use